Diabetes and heart failure (HF) are two of the most prevalent chronic conditions, often coexisting in the same patient and compounding each other's effects. Prevention and early detection are critical in managing HF, especially in patients with poor glycemic control. NT-proBNP (N-terminal pro b-type natriuretic peptide) is a key biomarker for early heart failure screening, with elevated levels indicating increased cardiac stress and potential worsening of HF.
Regular NT-proBNP screening in high-risk patients, such as those with diabetes, enables timely interventions. Also, given the cardiovascular risks of poorly managed diabetes, an integrated care approach is essential. Self-monitoring blood glucose (SMBG) plays a crucial role in glycemic control for HF patients, allowing real-time tracking of blood sugar levels and timely adjustments to prevent hypoglycemia or hyperglycemia, which…
